The latest updates on our research and how it is improving people’s lives.
23 September 2020
Professor of Orthopaedic and Tropical Surgery and Consultant Orthopaedic and Spine Surgeon Chris Lavy has been awarded a prestigious honorary fellowship by the British Orthopaedic Association (BOA).
21 September 2020
A new study has revealed psoriatic arthritis may be activated by the same trigger in different patients. Researchers from the University of Oxford and the Wellcome Sanger Institute identified high levels of a specific receptor in immune cells from psoriatic arthritis patients, giving the strongest evidence yet of a single cause for the disease.
10 September 2020
Patients could benefit from a faster and more effective introduction of artificial intelligence (AI) innovations to diagnose and treat disease – thanks to the first international standards for reporting of clinical trials for AI.
9 September 2020
Men and women working in heavy manual occupations are twice as likely to suffer from knee osteoarthritis (OA), the most common joint disorder, compared to those in sedentary occupations according to a new study published in the prestigious journal Seminars in Arthritis and Rheumatism.
26 August 2020
Sarcoma cancer in Oxford was reorganised during the pandemic. Two studies reveal their success and serve as a guide to other units facing the similar challenge of supporting patients.
Largest global study on hydroxychloroquine safety finds increased cardiovascular risk with azithromycin
24 August 2020
The combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has been linked to significant cardiovascular risks including mortality, in the largest safety study ever performed on both HCQ and HCQ+AZM.
20 August 2020
Hip replacement patient Nick Birch scales his second mountain to raise funds for University research
18 August 2020
Research shows how IL-22 interacts with KRAS mutant tumours to promote excessive growth in colorectal cancer
13 August 2020
Researchers at NDORMS have identified four subgroups of knee osteoarthritis which will improve patient treatment and drug development.
10 August 2020
An international cohort of OHDSI collaborators obtain a grant from the COVID-19 Therapeutics Accelerator to lead an effort to compare the effectiveness of treatments, including corticosteroids such as dexamethasone, under current evaluation for COVID-19 across an international observational data network.
27 July 2020
The collaboration brings the European Health Data & Evidence Network (EHDEN) together with the European Medicines Agency and partners.
24 July 2020
Researchers at the University of Oxford are investigating the long-term health outcomes for patients who have been treated for severe COVID-19 disease in intensive care.
23 July 2020
The University of Oxford has awarded the title of Associate Professor to seven senior researchers at NDORMS, and three University Research Lecturer titles.
23 July 2020
Stay-at-home parents, cleaners, and blue-collar workers found to be more likely to develop osteoarthritis
1 July 2020
Professor Mark Coles was recently appointed to the governing body of the University’s newest graduate college.
29 June 2020
The key to swift treatments to cure the pain of rheumatoid arthritis has been found in the joints of people with the condition who are in long- term remission.
22 June 2020
Recognised for the part he played in the discovery of anti-TNF therapy, Dr Feldmann is now exploring whether the antibody can be effective for COVID-19.